Advertisement
AD

Main navigation

Japanese "Amazon" Rakuten to Resume XRP Trading

Advertisement
Thu, 2/09/2021 - 18:23
A
A
A
Japanese "Amazon" Rakuten to Resume XRP Trading
Cover image via stock.adobe.com
Read U.TODAY on
Google News

Major Japanese online retailing company Rakuten has announced that it’s going to resume XRP margin trading on its Rakuten Wallet exchange.

The service was halted on Dec. 24, two days after the U.S. Securities and Exchange Commission announced its landmark lawsuit against blockchain company Ripple.        

Rakuten Wallet notes that the cryptocurrency’s price discovery is now stable enough.    

Coinbase, Kraken, Binance U.S., Bitstamp and a slew of other exchanges are yet to reinstate trading in the U.S, with Ripple's fate hinging on the outcome of the lawsuit. 

As reported by U.Today, the expert discovery deadline has been extended to Nov. 12.

Advertisement

Related
Rakuten Wallet launched back in August 2019. Initially, only Bitcoin, Ether and Bitcoin Cash were available for spot trading.

In March 2020, the cryptocurrency exchange added margin trading for Litecoin and XRP.

This spring, the retail giant also allowed its customers to shop with cryptocurrencies across Japan.

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

A
A
A

Related articles

Advertisement
TopCryptoNewsinYourMailboxSubscribe
TopCryptoNewsinYourMailboxSubscribe
Advertisement
Advertisement
Subscribe to daily newsletter

Recommended articles

Latest Press Releases

Our social media
There's a lot to see there, too

Popular articles

Advertisement
AD